Cargando…

Effect of deoxycholate, amphotericin B and fongizone on transmissible gastroenteritis coronavirus

At a concentration of 2 μg/ml, neither amphotericin B nor deoxycholate had an inactivating effect upon transmissible gastroenteritis Coronavirus in-fectivity. However, amphothericin B stimulated plaque formatin in agarose and facilitated the entry of viral RNA into swine testis cells. The combinatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, T.D., Bottreau, E., Aynaud, J.M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Masson SAS 1987
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7135538/ https://www.ncbi.nlm.nih.gov/pubmed/32288187 http://dx.doi.org/10.1016/S0769-2617(87)80019-9

Ejemplares similares

Transmissible gastroenteritis (TGE) of swine: In vitro virus attachment and effects of polyanions and polycations
por: Nguyen, T.D., et al.
Publicado: (1987)

Natural infection with the porcine respiratory coronavirus induces protective lactogenic immunity against transmissible gastroenteritis
por: Bernard, S., et al.
Publicado: (1989)

Étude comparée de trois souches du coronavirus de la gastroentérite transmissible: Conditions de la réplicationvirale et de la synthèse des antigènes structuraux
por: Nguyen, T.D., et al.
Publicado: (1987)

Induction of lactogenic immunity to transmissible gastroenteritis virus of swine using an attenuated coronavirus mutant able to survive in the physicochemical environment of the digestive tract
por: Aynaud, J.M., et al.
Publicado: (1992)

Transmissible gastroenteritis coronavirus: surface antigens induced by virulent and attenuated strains
por: To, L.T., et al.
Publicado: (1992)

Induction of lactogenic immunity to transmissible gastroneteritis virus of swine using an attenuated coronavirus mutant able to survive in the physicochemical environment of the digestive tract
por: Aynaud, J.M., et al.
Publicado: (1991)

Lactogenic Immunity to Transmissible Gastroenteritis (TGE) of swine induced by the attenuated nouzilly strain of TGE virus: Passive protection of piglets and detection of serum and milk antibody classes by ELISA
por: Bernard, Serge, et al.
Publicado: (1990)

Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei
por: Le, Thuy, et al.
Publicado: (2019)

Acute hepatic injury with amphotericin B deoxycholate in an immunocompetent patient
por: Wagner, Jamie L., et al.
Publicado: (2016)

In vitro activities of amphotericin B deoxycholate and liposomal amphotericin B against 604 clinical yeast isolates
por: Montagna, Maria Teresa, et al.
Publicado: (2014)

Amphotericin B lipid complex: treatment of invasive fungal infections in patients refractory to or intolerant of amphotericin B deoxycholate
por: Chandrasekar, PH
Publicado: (2008)

Continuous versus Conventional Infusion of Amphotericin B Deoxycholate: A Meta-Analysis
por: Falagas, Matthew E., et al.
Publicado: (2013)

Liposomal and Deoxycholate Amphotericin B Formulations: Effectiveness against Biofilm Infections of Candida spp.
por: Rodrigues, Célia F., et al.
Publicado: (2017)

Successful Treatment of Protothecal Tenosynovitis in an Immunocompetent Patient using Amphotericin B Deoxycholate
por: Kim, Ji-Eun, et al.
Publicado: (2017)

Cyanotic Raynaud's phenomenon induced by amphotericin B deoxycholate: A case report
por: Hatem, Nayla A., et al.
Publicado: (2023)

Population Pharmacokinetic Model and Meta-analysis of Outcomes of Amphotericin B Deoxycholate Use in Adults with Cryptococcal Meningitis
por: Stott, Katharine E., et al.
Publicado: (2018)

Amphotericin B deoxycholate for relapse visceral leishmaniasis in Bangladesh: a cross-sectional study
por: Hasnain, Md Golam, et al.
Publicado: (2018)

Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against Leishmania martiniquensis In Vitro
por: Intakhan, Nuchpicha, et al.
Publicado: (2020)

Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis
por: Bicanic, Tihana, et al.
Publicado: (2015)

A Phase 3 Study of Micafungin Versus Amphotericin B Deoxycholate in Infants With Invasive Candidiasis
por: Benjamin, Daniel K., et al.
Publicado: (2018)

Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam
por: Buchanan, James, et al.
Publicado: (2021)

In vitro antifungal susceptibilities of Candida species to liposomal amphotericin B, determined using CLSI broth microdilution, and amphotericin B deoxycholate, measured using the Etest
por: Lovero, Grazia, et al.
Publicado: (2017)

Intravenous Itraconazole vs. Amphotericin B Deoxycholate for Empirical Antifungal Therapy in Patients with Persistent Neutropenic Fever
por: Park, Sun Hee, et al.
Publicado: (2006)

In vitro anti-Leishmania activity of 8-hydroxyquinoline and its synergistic effect with amphotericin B deoxycholate against Leishmania martiniquensis
por: Chanmol, Wetpisit, et al.
Publicado: (2022)

Efficacy of an Abbreviated Induction Regimen of Amphotericin B Deoxycholate for Cryptococcal Meningoencephalitis: 3 Days of Therapy Is Equivalent to 14 Days
por: Livermore, Joanne, et al.
Publicado: (2014)

Mechanisms of transmissible gastroenteritis coronavirus neutralization
por: Suñé, Carlos, et al.
Publicado: (1990)

Safety and efficacy of amphotericin-B deoxycholate inhalation in critically ill patients with respiratory Candida spp. colonization: a retrospective analysis
por: van der Geest, Patrick J, et al.
Publicado: (2014)

Genetic comparison of transmissible gastroenteritis coronaviruses
por: Wang, Pei-Hua, et al.
Publicado: (2023)

Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South Africa
por: Meiring, Susan, et al.
Publicado: (2016)

Genetic evolution and tropism of transmissible gastroenteritis coronaviruses
por: Sánchez, Carlos M., et al.
Publicado: (1992)

Expression of Immunogenic Glycoprotein S Polypeptides from Transmissible Gastroenteritis Coronavirus in Transgenic Plants()
por: Gómez, N., et al.
Publicado: (1998)

Efficacy and Safety of Voriconazole Versus Amphotericin B Deoxycholate Induction Treatment for HIV-Associated Talaromycosis: A Prospective Multicenter Cohort Study in China
por: Zhou, Yihong, et al.
Publicado: (2022)

1331. High direct costs caused by Cryptococcal meningitis treated with Amphotericin B deoxycholate in a public hospital in Lima, Peru. 2021-2022
por: Vilcarromero, Stalin, et al.
Publicado: (2023)

Antigenic homology among coronaviruses related to transmissible gastroenteritis virus
por: Sánchez, Carlos M., et al.
Publicado: (1990)

Antigenic structure of transmissible gastroenteritis virus nucleoprotein
por: Martín Alonso, J.M., et al.
Publicado: (1992)

Antigen selection and presentation to protect against transmissible gastroenteritis coronavirus
por: Enjuanes, Luis, et al.
Publicado: (1992)

Biochemical and biophysical characterization of the transmissible gastroenteritis coronavirus fusion core
por: Ma, Guangpeng, et al.
Publicado: (2005)

Residues involved in the antigenic sites of transmissible gastroenteritis coronavirus S glycoprotein
por: Gebauer, Fátima, et al.
Publicado: (1991)

Cellular immune responses of pigs after primary inoculation with porcine respiratory coronavirus or transmissible gastroenteritis virus and challenge with transmissible gastroenteritis virus
por: Brim, Theresa A., et al.
Publicado: (1995)

Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine
por: Saif, L.J., et al.
Publicado: (1994)

Cannot write session to /tmp/vufind_sessions/sess_u47o1k7jgh05rlmmdbd51b9nme